Hercle, an institutional infrastructure platform bridging stablecoins, digital assets, and cross-border settlement, today announced $60 million in new capital. The round features a $10 million equity investment led by F-Prime, with participation from Fulgur Ventures and Exponential Science, alongside a $50 million credit line to support the expansion of institutional services and global growth initiatives. To date, Hercle’s platform has processed more than $20 billion in transactions, enabling ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Senior Vice President Paul Negulescu has been named as one of the winners of this year’s Lasker~DeBakey Clinical Medical Research Award for his role “in the development of a novel, life-saving treatment for cystic fibrosis (CF) — namely, a triple-drug combination therapy, TRIKAFTA®, that has helped countless people with this genetic disease.” Dr. Negulescu is one of three awardees, alongside Jesús (Tito) González, a former ...

Rimini Street, Inc., (the “Company”) (Nasdaq: RMNI), a global provider of end-to-end enterprise software support and innovation solutions, and the leading third-party support provider for Oracle, SAP and VMware software, today announced the completion of the following capital market transactions thus far during the third fiscal quarter of 2025: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250911501018/en/Rimini Street Announces St...

FPT, a global technology and IT services provider, announces its appointment as a strategic partner in delivering digital solutions and professional services for one of Asia’s leading energy companies and a significant player in driving energy transition initiatives in Southeast Asia. The five-year agreement, worth 256 million USD, has also become FPT’s highest-valued contract to date. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20...

Transformation is now a way of life for global companies, with two-thirds (65%) undergoing wide-reaching or expanding organization-wide transformation initiatives. This is driven by regulatory change (including tariffs), technological disruption, and shifting customer needs, all of which are rated at 4.1/5 in importance. Confidence levels are high, with 95% expecting initiatives to deliver success, according to the inaugural Arthur D. Little (ADL) Global Transformation Study. Time frames vary...

Celltrion Pharm (KOSDAQ: 068706), a South Korean biopharmaceutical firm, said on September 16 that it has inked a strategic trilateral agreement with a multinational syringe manufacturer, Becton Dickinson France S.A.S. (BD), and its Korean branch BD Korea. The signing ceremony took place at Celltrion Pharm’s research center in Songdo, Incheon, with its President Yoo Young-ho in attendance alongside key officials from BD and BD Korea. This press release features multimedia. View the full releas...